Patents/Assignees

MEDIGENE IMMUNOTHERAPIES GmbH

7 patents in portfolio

US12590136utility2026
Engineered T Cells
0 cites
US12331095utility2025
Inducible T Cell Receptors and Uses Thereof
0 cites
US12240883utility2025
MAGEA1 Specific T Cell Receptors and Their Use
0 cites
US12195515utility2025
HA-1 Specific T Cell Receptors and Their Use
0 cites
US12173318utility2024
Enrichment of T Cells Using an Anti-cß Antibody
0 cites
US12103957utility2024
NYESO TCR
0 cites
US11732020utility2023
T Cell Receptors and Uses Thereof
0 cites